Lupin Banks On Key Products For U.S. Growth Revival
Tablets move along a conveyor on the production line at the Lupin Ltd. pharmaceutical plant (Photographer: Dhiraj Singh/Bloomberg)

Lupin Banks On Key Products For U.S. Growth Revival

Shares of Lupin Ltd. have declined by nearly a quarter in the last two years compared with the Nifty Pharma Index’s 15 percent decline. India’s fifth-largest generic drugmaker faces intense competi...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.